Canada Markets close in 5 hrs 34 mins

Global Viral Inactivation Market Trajectory & Analytics Report 2020: Kits & Reagents, Systems, Services, Vaccines and Therapeutics, Stem Cell, Blood, Tissue & Cellular and Gene Therapy - ResearchAndMarkets.com

·5 min read

The "Viral Inactivation - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Viral Inactivation Market to Reach $951.1 Million by 2027

Amid the COVID-19 crisis, the global market for Viral Inactivation estimated at US$443.1 Million in the year 2020, is projected to reach a revised size of US$951.1 Million by 2027, growing at a CAGR of 11.5% over the analysis period 2020-2027.

Kits & Reagents, one of the segments analyzed in the report, is projected to record a 11.5% CAGR and reach US$549.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Systems segment is readjusted to a revised 12.1% CAGR for the next 7-year period.

The U. S. Market is Estimated at $130.7 Million, While China is Forecast to Grow at 11.1% CAGR

The Viral Inactivation market in the U. S. is estimated at US$130.7 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$166.8 Million by the year 2027 trailing a CAGR of 11.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.2% and 9.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

Services Segment to Record 10.8% CAGR

In the global Services segment, USA, Canada, Japan, China and Europe will drive the 10.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$57.2 Million in the year 2020 will reach a projected size of US$115.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$112.3 Million by the year 2027.

The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

  • Charles River Laboratories International, Inc.

  • Clean Cells Inc.

  • Danaher Corporation

  • Merck KgaA

  • Parker Hannifin Corporation

  • Rad Source Technologies, Inc.

  • Sartorius AG

  • SGS Group (SGS SA)

  • Texcell, Inc.

  • V. I. P. S. SA

  • WuXi AppTec Group

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares

  • Viral Inactivation Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • Viral Inactivation Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027

  • Viral Inactivation Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019

  • Viral Inactivation Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027

  • Kits & Reagents (Product) World Market by Region/Country in US$ Thousand: 2020 to 2027

  • Kits & Reagents (Product) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019

  • Kits & Reagents (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027

  • Systems (Product) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027

  • Systems (Product) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019

  • Systems (Product) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027

  • Services (Product) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027

  • Services (Product) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to 2019

  • Services (Product) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027

  • Vaccines and Therapeutics (Application) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027

  • Vaccines and Therapeutics (Application) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019

  • Vaccines and Therapeutics (Application) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027

  • Stem Cell Products (Application) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2020-2027

  • Stem Cell Products (Application) Global Historic Analysis in US$ Thousand by Region/Country: 2012-2019

  • Stem Cell Products (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027

  • Blood and Blood Products (Application) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2020 through 2027

  • Blood and Blood Products (Application) Analysis of Historic Sales in US$ Thousand by Region/Country for the Years 2012 to 2019

  • Blood and Blood Products (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027

  • Tissue/ Tissue Products (Application) Global Opportunity Assessment in US$ Thousand by Region/Country: 2020-2027

  • Tissue/ Tissue Products (Application) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019

  • Tissue/ Tissue Products (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027

  • Cellular and Gene Therapy (Application) Worldwide Sales in US$ Thousand by Region/Country: 2020-2027

  • Cellular and Gene Therapy (Application) Historic Demand Patterns in US$ Thousand by Region/Country: 2012-2019

  • Cellular and Gene Therapy (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

  • Market Facts & Figures

  • Viral Inactivation Market Share (in %) by Company: 2019 & 2025

  • Market Analytics

  • States Viral Inactivation Market Estimates and Projections in US$ Thousand by Product: 2020 to 2027

  • Viral Inactivation Market by Product: A Historic Review in US$ Thousand for 2012-2019

  • Viral Inactivation Market Share Breakdown by Product: 2012 VS 2020 VS 2027

  • Viral Inactivation Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027

  • Viral Inactivation Historic Demand Patterns by Application in US$ Thousand for 2012-2019

  • Viral Inactivation Market Share Breakdown by Application: 2012 VS 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 42

For more information about this report visit https://www.researchandmarkets.com/r/nr1p16

View source version on businesswire.com: https://www.businesswire.com/news/home/20201023005251/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900